Company: SNWV
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001628280-25-050280
Chunk: 91

Company: SANUWAVE Health, Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 8
Chunk 91
---
 that is also reported on the condensed consolidated statements of comprehensive income (loss). The measure of segment assets is reported on the condensed consolidated balance sheets as total assets.The CODM uses gross profit to evaluate income (loss) generated from segment assets (return on assets) in deciding whether to reinvest profits or to apply them to other parts of the entity.

22

Net income (loss) is used to monitor budget versus actual results. The CODM also uses net income (loss) in competitive analysis by benchmarking to competitors. The competitive analysis along with the monitoring of budgeted versus actual results are used in assessing performance of the segment and in establishing management’s compensation.Management has determined that Morgan Frank, CEO, is the CODM.The following table sets forth our condensed consolidated statements of comprehensive income (loss) used by the CODM:Three Months Ended September 30,Nine Months Ended September 30,(in thousands)2025202420252024Revenue$11,451 $9,360 $30,957 $22,308 Cost of Revenues2,526 2,293 6,690 5,799 Gross Margin8,925 7,067 24,267 16,509 Operating Expenses:General and administrative4,810 2,545 13,316 8,059 Selling and marketing2,081 2,202 5,286 4,468 Research and development345 161 747 519 Depreciation and amortization222 206 588 568 Operating Income1,467 1,953 4,330 2,895 Total Other Income (Expense)8,858 (22,610)1,374 (21,519)Net Income (Loss)$10,325 $(20,657)$5,704 $(18,624)

23

 Item 2.   MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion and analysis of our financial condition and results of operations together with our unaudited condensed consolidated financial statements and the related notes appearing elsewhere in this report, and together with our audited consolidated financial statements, related notes and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” as of and for the year ended December 31, 2024 included in our Annual Report on Form 10-K, filed with the SEC on March 20, 2025 (the “